WallStreetZenWallStreetZen

NASDAQ: MBRX
Moleculin Biotech Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Moleculin Biotech revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MBRX annual revenue was $0.0, with N/A growth year-over-year.

MBRX revenue history

Current Revenue
$0.0
Current Earnings
-$23.2M
Current Profit Margin
0%

Be the first to know when MBRX announces revenue.

MBRX Revenue History By Year

MBRX Yearly RevenueMBRX RevenueMBRX ChangeMBRX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A

1 of 1

Moleculin Biotech Revenue FAQ

What was MBRX's revenue last quarter?

On Invalid Date, Moleculin Biotech (NASDAQ: MBRX) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Moleculin Biotech's revenue was $0.00.

What was Moleculin Biotech's revenue in 2024?

Moleculin Biotech's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Moleculin Biotech make in a day?

Based on Moleculin Biotech annual revenue for the past five years, MBRX makes an average of $0.00 per day.

What was Moleculin Biotech's annual revenue growth in the past year?

As of Q2 2025, Moleculin Biotech's revenue has grown null year over year. Moleculin Biotech's revenue in the past year totaled $0.00.

How much does Moleculin Biotech make in a year?

Moleculin Biotech's revenue by year for the past five years is:
  • Moleculin Biotech's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Moleculin Biotech's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Moleculin Biotech's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Moleculin Biotech's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Moleculin Biotech's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.